Tool
Stock screener
Filter the 3753 US stocks StockVane tracks, then sort by any column. Results carry the same Quant Rating shown on each stock’s page.
Top Quant-ratedLarge-cap dividend payersCheap & top-ratedBeaten-down (down 20%+ 1yr)High yield (4%+)Mega-cap winners
23 matches
| Company | 60d | Last | Chg% | Mkt cap | P/E | Yield | 1-yr | Quant ↑ |
|---|---|---|---|---|---|---|---|---|
| Regencell BioscienceRGC | 4.18 | -4.13% | $2.07B | -- | -- | -66.5% | E 2 | |
| EvotecEVO | 1.32 | -8.97% | $469.11M | -- | -- | -55.6% | E 5 | |
| Aquestive TherapeuticsAQST | 3.46 | -6.61% | $434.88M | -- | -- | -39.5% | E 9 | |
| Supernus PharmaceuticalsSUPN | 28.61 | +0.92% | $5.94B | -- | -- | -36.9% | E 11 | |
| ZoetisZTS | 79.11 | -2.08% | $32.14B | 13.34 | 2.64% | -34.2% | E 14 | |
| Prestige Consumer HealthcarePBH | 49.63 | +0.06% | $2.35B | 15.32 | -- | -16.5% | D 24 | |
| ANI PharmaceuticalsANIP | 68.55 | -0.84% | $1.56B | 13.63 | -- | -14.0% | D 24 | |
| HaleonHLN | 9.07 | +0.22% | $39.76B | 19.14 | 2.09% | -6.3% | D 37 | |
| BioCryst PharmaceuticalsBCRX | 7.22 | -1.37% | $1.86B | -- | -- | +3.6% | D 45 | |
| Dr. Reddy's LaboratoriesRDY | 14.89 | +0.40% | $12.41B | 41.36 | 0.56% | +7.8% | C 48 | |
| Neurocrine BiosciencesNBIX | 150.57 | -3.84% | $15.24B | 22.34 | -- | +6.2% | C 51 | |
| Amphastar PharmaceuticalsAMPH | 28.25 | +0.50% | $1.20B | 12.96 | -- | +8.6% | C 54 | |
| United TherapeuticsUTHR | 554.73 | -0.78% | $23.63B | 20.94 | -- | +16.8% | C 60 | |
| Elanco Animal HealthELAN | 25.74 | -2.09% | $12.87B | -- | -- | +15.7% | C 65 | |
| Cronos GroupCRON | 3.04 | -1.30% | $1.11B | 19.00 | -- | +28.3% | C 74 | |
| PerrigoPRGO | 15.94 | -0.62% | $2.21B | -- | 7.28% | +35.0% | C 78 | |
| Ironwood PharmaceuticalsIRWD | 4.70 | -0.21% | $778.09M | 5.22 | -- | +48.7% | C 87 | |
| Amylyx PharmaceuticalsAMLX | 26.02 | -0.69% | $3.35B | -- | -- | +77.4% | C 95 | |
| Trulieve CannabisTRLV | 8.68 | -7.17% | $1.68B | -- | -- | +61.3% | D 95 | |
| LiquidiaLQDA | 54.43 | -3.88% | $4.90B | -- | -- | +87.0% | D 96 | |
| LantheusLNTH | 102.10 | 0.00% | $6.68B | 25.40 | -- | +82.9% | C 97 | |
| Xeris PharmaceuticalsXERS | 16.97 | +2.11% | $3.10B | -- | -- | +148.5% | C 98 | |
| Eton PharmaceuticalETON | 60.85 | -0.83% | $1.76B | 39.51 | -- | +269.7% | C 100 |
Reference only, not investment advice. A screen is a starting point, not a buy list. Quant Rating method: Data & Methodology.